Company Description
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific.
It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates.
The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.
It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024.
XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Country | United States |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 13 |
CEO | Owen P. Hughes Jr. |
Contact Details
Address: 2200 Powell Street, Suite 310 Emeryville, California 94608 United States | |
Phone | 510-204-7239 |
Website | xoma.com |
Stock Details
Ticker Symbol | XOMA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000791908 |
CUSIP Number | 98419J206 |
ISIN Number | US98419J2069 |
Employer ID | 52-2154066 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Owen P. Hughes Jr. | Chief Executive Officer and Director |
Thomas M. Burns | Senior Vice President of Finance and Chief Financial Officer |
Brad Sitko | Chief Investment Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 9, 2024 | 8-K | Current Report |
Jun 17, 2024 | EFFECT | Notice of Effectiveness |
Jun 17, 2024 | EFFECT | Notice of Effectiveness |
Jun 13, 2024 | 8-K/A | [Amend] Current report |
May 30, 2024 | 8-K | Current Report |
May 16, 2024 | 8-K | Current Report |
May 9, 2024 | 8-K | Current Report |
May 9, 2024 | 10-Q | Quarterly Report |
Apr 30, 2024 | 8-K | Current Report |
Apr 25, 2024 | 8-K | Current Report |